drugset / Trial / NCT04702503
Study of WP1220 for the Treatment of Adult Subjects With Cutaneous T-Cell Lymphoma (CTCL)
NaSingle-groupOpen-labelTreatment
Summary
Single center, pilot study to evaluate the safety and efficacy topical administration of WP1220 in subjects with Stage I, II or III Mycosis Fungoides (CTCL)
Timeline
- Start
- 2019-03-08
- Primary completion
- 2019-11-15
- Completion
- 2020-11-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MOL4239 | Small molecule | 10 % | Topical |